| CEO |
Seng-ho Jeon |
- Head of Global Strategy Team, Daewoong Pharmaceutical
- Head of Global Business Division,
Daewoong Pharmaceutical
|
Mar 2018 |
Mar 2024 |
Registered |
| Chang-jae Lee |
- Head of ETC Division,
Daewoong Pharmaceutical
- Head of Marketing Division,
Daewoong Pharmaceutical
- Executive Director, Daewoong
|
Jan 2022 |
Mar 2024 |
Registered |
| Executive Director |
Jae-choon Yoon |
- Head of Management Support Division, Daewoong Pharmaceutical
- Chief Operating Officer, Daewoong Pharmaceutical
- Chief Executive Officer, Hanall Biopharma
- Chief Executive Officer,
Daewoong Bio
- Chief Executive Officer, Daewoong Pharmaceutical (Current)
|
Mar 2018 |
Mar 2024 |
Registered |
| Outside Director |
Hong-cheol Kim |
- Director, Corporate Research
- Outside Director, Hanall Biopharma
- Auditor, Bridge Biotherapeutics
|
Mar 2018 |
Mar 2024 |
Registered |
| Young-jin Kim |
- The Catholic Univ. of Korea Catholic
Medical Center
- Director of Trauma Center,
Hyosung Sejong Hospital
- Adjunct Assistant Professor, The Catholic Univ. of Korea College of Medicine (Current)
- President, Guro Wooridul Clinic (Current)
|
Mar 2021 |
Mar 2024 |
Registered |